Literature DB >> 27311832

CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype.

Leonie A Menke1, Martine J van Belzen2, Marielle Alders3, Francesca Cristofoli4, Nadja Ehmke5, Patricia Fergelot6, Alison Foster7,8, Erica H Gerkes9, Mariëtte J V Hoffer2, Denise Horn5, Sarina G Kant2, Didier Lacombe6, Eyby Leon10, Saskia M Maas1,3, Daniela Melis11, Valentina Muto12, Soo-Mi Park13, Hilde Peeters4, Dorien J M Peters14, Rolph Pfundt15, Conny M A van Ravenswaaij-Arts9, Marco Tartaglia12, Raoul C M Hennekam16.   

Abstract

Mutations in CREBBP cause Rubinstein-Taybi syndrome. By using exome sequencing, and by using Sanger in one patient, CREBBP mutations were detected in 11 patients who did not, or only in a very limited manner, resemble Rubinstein-Taybi syndrome. The combined facial signs typical for Rubinstein-Taybi syndrome were absent, none had broad thumbs, and three had only somewhat broad halluces. All had apparent developmental delay (being the reason for molecular analysis); five had short stature and seven had microcephaly. The facial characteristics were variable; main characteristics were short palpebral fissures, telecanthi, depressed nasal ridge, short nose, anteverted nares, short columella, and long philtrum. Six patients had autistic behavior, and two had self-injurious behavior. Other symptoms were recurrent upper airway infections (n = 5), feeding problems (n = 7) and impaired hearing (n = 7). Major malformations occurred infrequently. All patients had a de novo missense mutation in the last part of exon 30 or beginning of exon 31 of CREBBP, between base pairs 5,128 and 5,614 (codons 1,710 and 1,872). No missense or truncating mutations in this region have been described to be associated with the classical Rubinstein-Taybi syndrome phenotype. No functional studies have (yet) been performed, but we hypothesize that the mutations disturb protein-protein interactions by altering zinc finger function. We conclude that patients with missense mutations in this specific CREBBP region show a phenotype that differs substantially from that in patients with Rubinstein-Taybi syndrome, and may prove to constitute one (or more) separate entities.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CREBBP; RSTS; Rubinstein-Taybi syndrome; case series; clinical features; exon 30; exon 31; genotype-phenotype correlation; intellectual disability; mutation; syndrome; whole exome sequencing

Mesh:

Substances:

Year:  2016        PMID: 27311832     DOI: 10.1002/ajmg.a.37800

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders.

Authors:  Gloria Negri; Pamela Magini; Donatella Milani; Milena Crippa; Elisa Biamino; Maria Piccione; Stefano Sotgiu; Chiara Perrìa; Giuseppina Vitiello; Marina Frontali; Antonella Boni; Elisabetta Di Fede; Maria Chiara Gandini; Elisa Adele Colombo; Michael J Bamshad; Deborah A Nickerson; Joshua D Smith; Italia Loddo; Palma Finelli; Marco Seri; Tommaso Pippucci; Lidia Larizza; Cristina Gervasini
Journal:  Hum Genet       Date:  2019-02-26       Impact factor: 4.132

Review 2.  Genetics of Short Stature.

Authors:  Youn Hee Jee; Anenisia C Andrade; Jeffrey Baron; Ola Nilsson
Journal:  Endocrinol Metab Clin North Am       Date:  2017-02-23       Impact factor: 4.741

3.  Menke-Hennekam Syndrome: A Literature Review and a New Case Report.

Authors:  Aurora Sima; Roxana Elena Smădeanu; Anca Angela Simionescu; Florina Nedelea; Andreea-Maria Vlad; Cristina Becheanu
Journal:  Children (Basel)       Date:  2022-05-22

4.  Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes.

Authors:  Simone Martinelli; Oliver H F Krumbach; Francesca Pantaleoni; Simona Coppola; Ehsan Amin; Luca Pannone; Kazem Nouri; Luciapia Farina; Radovan Dvorsky; Francesca Lepri; Marcel Buchholzer; Raphael Konopatzki; Laurence Walsh; Katelyn Payne; Mary Ella Pierpont; Samantha Schrier Vergano; Katherine G Langley; Douglas Larsen; Kelly D Farwell; Sha Tang; Cameron Mroske; Ivan Gallotta; Elia Di Schiavi; Matteo Della Monica; Licia Lugli; Cesare Rossi; Marco Seri; Guido Cocchi; Lindsay Henderson; Berivan Baskin; Mariëlle Alders; Roberto Mendoza-Londono; Lucie Dupuis; Deborah A Nickerson; Jessica X Chong; Naomi Meeks; Kathleen Brown; Tahnee Causey; Megan T Cho; Stephanie Demuth; Maria Cristina Digilio; Bruce D Gelb; Michael J Bamshad; Martin Zenker; Mohammad Reza Ahmadian; Raoul C Hennekam; Marco Tartaglia; Ghayda M Mirzaa
Journal:  Am J Hum Genet       Date:  2018-01-25       Impact factor: 11.025

5.  A Novel CREBBP in-Frame Deletion Variant in a Chinese Girl with Atypical Rubinstein-Taybi Syndrome Phenotypes.

Authors:  Qingming Wang; Wanfang Xu; Yanhui Liu; Haiming Yuan
Journal:  J Mol Neurosci       Date:  2020-08-25       Impact factor: 3.444

Review 6.  Reprogramming of the epigenome in neurodevelopmental disorders.

Authors:  Khadija D Wilson; Elizabeth G Porter; Benjamin A Garcia
Journal:  Crit Rev Biochem Mol Biol       Date:  2021-10-02       Impact factor: 8.697

7.  Clinical description and mutational profile of a Moroccan series of patients with Rubinstein Taybi syndrome.

Authors:  Siham Chafai Elalaoui; Wiam Smaili; Julien Van-Gils; Patricia Fergelot; Ilham Ratbi; Mariam Tajir; Benoit Arveiler; Didier Lacombe; Abdelaziz Sefiani
Journal:  Afr Health Sci       Date:  2021-06       Impact factor: 0.927

8.  A Case of Common Variable Immunodeficiency with CREBP Gene Mutation without Rubinstein Taybi Syndrome Features.

Authors:  Ugur Musabak; Serdar Ceylaner; Tuba Erdogan; Ebru Sebnem Ayva
Journal:  Case Reports Immunol       Date:  2022-07-04

9.  Whole-exome sequencing identified a novel variant in an Iranian patient affected by pycnodysostosis.

Authors:  Ehsan Razmara; Homeyra Azimi; Amirreza Bitaraf; Mohammad Ali Daneshmand; Mohammad Galehdari; Maryam Dokhanchi; Elika Esmaeilzadeh-Gharehdaghi; Masoud Garshasbi
Journal:  Mol Genet Genomic Med       Date:  2020-01-15       Impact factor: 2.183

Review 10.  Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder.

Authors:  Julien Van Gils; Frederique Magdinier; Patricia Fergelot; Didier Lacombe
Journal:  Genes (Basel)       Date:  2021-06-24       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.